Kiniksa Pharmaceuticals International, plc
KNSA
$27.74
$0.772.86%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/2/2025
-
MarketBeat
5/2/2025
-
Ticker Report
5/1/2025
-
MarketBeat
5/1/2025
-
MarketBeat
5/1/2025
-
Simply Wall St
5/1/2025
-
TipRanks Financial Blog
4/30/2025
-
Simply Wall St
4/30/2025
-
Globe Newswire
4/30/2025
-
Tickeron - Stocks
4/30/2025
-
Tickeron - Stocks
4/30/2025
-
TipRanks Financial Blog
4/30/2025
-
GuruFocus
4/29/2025
-
SeekingAlpha
4/29/2025
-
Market News Video
4/29/2025
-
Market News Video
4/29/2025
-
GuruFocus
4/29/2025
-
Zacks Investment Research
4/29/2025
-
GuruFocus
4/29/2025
-
GuruFocus
4/29/2025
-
SeekingAlpha.com: All News
4/29/2025
-
Globe Newswire
4/29/2025
-
MarketBeat
4/29/2025
-
GuruFocus
4/29/2025
-
GuruFocus
4/28/2025
-
Benzinga
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, April 29, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Jul 21 and 25 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 431 9100
Address
23 Old Bond Street
London, WIS 4PZ
London, WIS 4PZ
Country
Year Founded
Business Description
Sector
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications...
more